NKTR Deadline: Rosen Law Firm Urges Nektar Therapeutics (NASDAQ: NKTR) Stockholders to Contact the Firm for Information About Their RightsApril 27, 2026
Share Twitter Facebook LinkedIn Email This week, Bobbi Conner talks with MUSC’s Dr. Gina Perez about lifestyle routines to help manage multiple sclerosis (MS).Read More
The sub 2-hour marathon shoe hit the shelves this morning — but will cost wannabe runners up to $650April 27, 2026